Results 101 to 110 of about 29,053 (244)

Development and characterisation of improved unifocal primary mouse lung cancer models with metastatic potential

The Journal of Pathology, Volume 266, Issue 4-5, Page 405-420, August 2025.
Abstract Lung cancer is the leading cause of cancer‐related death globally. To better understand the biology of lung cancer, mouse models have been developed using either tail vein‐injected tumour cell lines or genetically modified mice. The current gold‐standard models typically present with multiple lung foci.
Ana‐Rita Pedrosa, Alejandro Castillo‐Kauil, Yuliia Kravchuk, Louise Reynolds, Bruce Williams, David Moore, Cameron Lang, Srinivas Allanki, Eleni Maniati, Alexandros Hardas, Jozafina Haj, Rebecca Drake, Julie Cleaver, Julie Foster, Jana Kim, Ester Stern, Jane Sosabowski, Gilbert O. Fruhwirth, Erik Sahai, Ori Wald, Kairbaan Hodivala‐Dilke   +20 more
wiley   +1 more source

213Bi-[DOTA0, Tyr3]Octreotide Peptide Receptor Radionuclide Therapy of Pancreatic Tumors in a Preclinical Animal Model [PDF]

, 2006
Jeffrey P. Norenberg, Boudewijn J. Krenning, Inge R. Konings, Donna F. Kusewitt, Tapan K. Nayak, Tamara L. Anderson, Marion de Jong, Kayhan Garmestani, Martin W. Brechbiel, Larry K. Kvols   +9 more
openalex   +1 more source

Peptide‐Drug Conjugates: A New Hope for Cancer

Journal of Peptide Science, Volume 31, Issue 8, August 2025.
Peptide‐drug conjugates (PDCs) are emerging cancer therapeutics inspired by antibody‐drug conjugates, offering targeted delivery via peptide ligands. Despite structural versatility, challenges like instability and rapid clearance hinder clinical progress.
Amy Armstrong, Fleur Coburn, Yanyamba Nsereko, Othman Al Musaimi   +3 more
wiley   +1 more source

Radionuclide therapy [PDF]

Clinical Medicine, 2006
openaire   +2 more sources

Update on radionuclide therapy in oncology.

Oncology letters, 2017
Unstable isotopes and their capacity to emit ionizing radiation have been employed in clinical practice not only for diagnostic, but also for therapeutic purposes, with significant contribution in several fields of medicine and primarily in the management of oncologic patients.
Nitipir, Cornelia, Niculae, Dana, Orlov, Cristina, Barbu, Maria Alexandra, Popescu, Bogdan, Popa, Ana Maria, Pantea, Anca Mihaela Stoian, Stanciu, Adina Elena, Galateanu, Bianca, Ginghina, Octav, Papadakis, Georgios Z., Izotov, Boris N., Spandidos, Demetrios A., Tsatsakis, Aristides M., Negrei, Carolina   +14 more
openaire   +2 more sources

AAPM medical physics practice guideline 13.a: HDR brachytherapy, part B

Journal of Applied Clinical Medical Physics, Volume 26, Issue 7, July 2025.
Abstract The goal of this report is to assist the clinical medical physicist in assuring that key quality standards and practice considerations are met to ensure safe, reliable, and reproducible high dose rate (HDR) brachytherapy (BT) treatment. This guideline has been developed to provide appropriate minimum standards for such services.
Susan L. Richardson, Arjit K. Baghwala, Gil'ad N. Cohen, Claire Dempsey, Bruce Libby, Christopher S. Melhus, Robin A. Miller, Daniel J. Scanderbeg, Samantha J. Simiele   +8 more
wiley   +1 more source

Brass‐mesh‐bolus–Radiation safety analysis and activation characterization following high energy photon treatment

Journal of Applied Clinical Medical Physics, Volume 26, Issue 7, July 2025.
Purpose Brass‐mesh‐bolus (BMB) has been proposed as an alternative to water‐equivalent bolus due to its ease of setup and conformality to patient contour. In high‐energy beams, BMB can become radioactive and pose a potential exposure risk to therapists from frequent exposure while handling.
Richard C. Mallory, Kyle Woods, Kiernan McCullough   +2 more
wiley   +1 more source

CT Imaging‐based radiomics predicts the pain relief of Strontium‐89 in treating tumor‐induced bone metastases

Journal of Applied Clinical Medical Physics, Volume 26, Issue 7, July 2025.
Abstract Background Bone metastasis is a common complication in advanced malignancies, often resulting in severe pain and reduced quality of life. Radiopharmaceuticals like Strontium‐89 (89Sr) are commonly used for palliative treatment to alleviate bone pain associated with metastases.
Danzhou Fang, Yaofeng Xiao, Shunhao Zhou, Feng Shi, Yuwei Xia, Gengbiao Yuan, Xiaojiao Xiang   +6 more
wiley   +1 more source

Radionuclide Therapy

, 2000
Bert M. Coursey, Ravinder Nath
openalex   +1 more source

Erratum: “Dosimetric characterization of radionuclides for systemic tumor therapy: Influence of particle range, photon emission, and subcellular distribution” [Med. Phys. 33, 3260–3269 (2006)] [PDF]

, 2007
Helena Uusijärvi, Peter Bernhardt, Thomas Ericsson, Eva Forssell‐Aronsson   +3 more
openalex   +1 more source